Adverum Biotechnologies Inc (ADVM)

NASDAQ
2.315
-0.005(-0.22%)
  • Volume:
    1,008,477
  • Bid/Ask:
    2.310/2.320
  • Day's Range:
    2.310 - 2.390

ADVM Overview

Prev. Close
2.32
Day's Range
2.31-2.39
Revenue
7.5M
Open
2.33
52 wk Range
2.255-19.25
EPS
-1.35
Volume
1,008,477
Market Cap
228.19M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,483,232
P/E Ratio
-
Beta
1.13
1-Year Change
-86.85%
Shares Outstanding
97,934,777
Next Earnings Date
Aug 05, 2021
What is your sentiment on Adverum Biotechnologies Inc?
or
Vote to see community's results!

Adverum Biotechnologies Inc News

Adverum Biotechnologies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Adverum Biotechnologies Inc Company Profile

Adverum Biotechnologies Inc Company Profile

Employees
167

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Read More
  • long term investment
    0
    • great bargain buy right now
      1
      • great bargain!!
        0
        • this is not a stocks
          0
          • Why ?
            0
        • good oportunity to.buy
          0
          • Short it
            0
            • Too late
              0
            • very late
              0
          • what is going with it
            0
            • If I were you, I will start buying in segments.
              0
              • Quick Buy call on ADVM. CMP 4.0 fell 60% today.. going to recover 40% in one hour. Hurry make your profit 40% today..
                0
                • Blabla
                  0
                • really is blabla
                  0
              • will close on 4.40
                0
                • any news on why it is down today?
                  0
                  • Time to buy ? Or
                    0
                    • ***happens, lets see the closing, still its worth 5$ i think.
                      0
                      • 4.10.
                        0
                        • Very bad
                          0
                          • Why?
                            0
                            • serious adverse effects
                              0
                          • Long Adverum
                            1
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.